Clinical Trial Update: NMBA Reversal and Postoperative Urinary Retention

View source ↗

Summary

This clinical trial update discusses reversal of neuromuscular blocking agents and the occurrence or management of postoperative urinary retention, highlighting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Retention

Drugs mentioned

• Atropine (atropine)
• Glycopyrrolate (glycopyrrolate)
• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Neuromuscular Blocking Agents, Urinary Retention After Procedure | Status: ACTIVE_NOT_RECRUITING